Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
CTNG
Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern
1 other identifier
observational
300
1 country
1
Brief Summary
There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health. Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 4, 2009
CompletedFirst Posted
Study publicly available on registry
September 9, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedJanuary 13, 2011
January 1, 2011
1 year
September 4, 2009
January 12, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection
6 months
Study Arms (1)
HIV-infection
All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent
Eligibility Criteria
All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months
You may qualify if:
- HIV-infection
- Attending the Clinic for Infectious Diseases from May 09 to November 09
- Sexually active during the last 12 months
- Written informed consent
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Insel Gruppe AG, University Hospital Bernlead
- Pfizercollaborator
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Clinic for Infectious Diseases, Berne University Hospital
Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hansjakob Furrer, MD
University Hospital Berne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 4, 2009
First Posted
September 9, 2009
Study Start
May 1, 2009
Primary Completion
May 1, 2010
Study Completion
June 1, 2010
Last Updated
January 13, 2011
Record last verified: 2011-01